Boudewijn L. M. de Jonge

<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015

James A. Karlowsky, Krystyna M. Kazmierczak, Boudewijn L. M. de Jonge et al. · Antimicrobial Agents and Chemotherapy · 2017 · 183 citations · Full text

<i>In Vitro</i> Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)

Wright W. Nichols, Boudewijn L. M. de Jonge, Krystyna M. Kazmierczak et al. · Antimicrobial Agents and Chemotherapy · 2016 · 160 citations · Full text

Pathogenic Microbiology, Antibiotic Resistance, Bacterial Pathogens +23

<i>In Vitro</i> Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)

Boudewijn L. M. de Jonge, James A. Karlowsky, Krystyna M. Kazmierczak et al. · Antimicrobial Agents and Chemotherapy · 2016 · 155 citations · Full text

Extended-spectrum β-Lactamases, Pathogenic Microbiology, Klebsiella Pneumoniae +19

Exploitation of structural and regulatory diversity in glutamate racemases

T. Lundqvist, Stewart L. Fisher, Günther Kern et al. · Nature · 2007 · 138 citations · Full text

Glutamate Racemases, Natural Sciences, Genetics +6

Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Program, 2012 to 2017

Krystyna M. Kazmierczak, James A. Karlowsky, Boudewijn L. M. de Jonge et al. · Antimicrobial Agents and Chemotherapy · 2021 · 105 citations · Full text